Showing results (31-40 of 609) with videos related to

Sort By:
Pageof 61
BJUI Compass|April 27, 2022
Local versus general anesthesia transperineal prostate biopsy: Tolerability, cancer detection, and complicationsDonnacha Hogan, Abbie Kanagarajah, Henry H Yao, et al.
BJUI Compass|April 27, 2022
Aquablation therapy in large prostates (80-150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3-year trial resultsKevin C Zorn, Mohamed Bidair, Andrew Trainer, et al.
BJUI Compass|April 27, 2022
Long-term outcomes of outpatient laser ablation for recurrent non-muscle invasive bladder cancer: A retrospective cohort studySarika Grover, Siddarth Raj, Beth Russell, et al.
BJUI Compass|April 27, 2022
Prognostic impact of eligibility for adjuvant immunotherapy in locally advanced urothelial cancerYuki Miura, Shingo Hatakeyama, Toshikazu Tanaka, et al.
BJUI Compass|April 27, 2022
Virtual reality tumor navigated robotic radical prostatectomy by using three-dimensional reconstructed multiparametric prostate MRI and 68Ga-PSMA PET/CT images: A useful tool to guide the robotic surgery?Abdullah Erdem Canda, Sertac Fatih Aksoy, Emre Altinmakas, et al.
BJUI Compass|April 27, 2022
Frailty is a predictor of moderate to severe pain after robot-assisted laparoscopic prostatectomy: A case-control study (FRAP study)Masaki Momota, Shingo Hatakeyama, Osamu Soma, et al.
BJUI Compass|April 27, 2022
Radical Cystectomy in England from 2013 to 2019 on 12,644 patients: An analysis of national trends and comparison of surgical approaches using Hospital Episode Statistics dataAshwin Sunil Tamhankar, David Thurtle, Alexander Hampson, et al.
BJUI Compass|April 27, 2022
Survey on ureTEric draiNage post uncomplicaTed ureteroscopy (STENT)Nikita R Bhatt, Kenneth MacKenzie, Taimur T Shah, et al.
BJUI Compass|April 27, 2022
A multi-institutional randomized controlled trial comparing first-generation transrectal high-resolution micro-ultrasound with conventional frequency transrectal ultrasound for prostate biopsyC P Pavlovich, M E Hyndman, G Eure, et al.
BJUI Compass|April 27, 2022
Abiraterone acetate plus Prednisone/Prednisolone compared with Enzalutamide in metastatic castration resistant prostate cancer before or after chemotherapy: A retrospective study of real-world data (ACES)Prantik Das, Sarah Taylor, James Price, et al.
Pageof 61